Judge Allows Pfizer, Moderna Defenses In GSK Vax IP Dispute
A Delaware federal judge on Tuesday permitted Pfizer and Moderna to move ahead with their arguments that GlaxoSmithKline patents the company claims are infringed by the COVID-19 vaccines are unenforceable because...To view the full article, register now.
Already a subscriber? Click here to view full article